The quest to reduce stroke treatment delays at a Melbourne metropolitan primary stroke centre over the past two decades. Issue 11 (13th June 2022)

• Record Type: Journal Article
• Authors: Park, Peter S. W.; Frost, Tanya; Tan, Shuangyue; Wong, Joseph; Pope, Alun; Dewey, Helen M.; Choi, Philip M. C.
• Is Part Of: Internal medicine journal. Volume 52:Issue 11(2022)
• Page Start: 1978
• Page End: 1985
• Publication Date: 2022-06-13
• Subjects: stroke -- tissue plasminogen activator -- quality improvement -- cohort study -- human; Medicine -- Periodicals; 616
• DOI: 10.1111/imj.15429
• Languages: English
• ISSNs: 1444-0903

Abstract

Abstract: Background: Reducing door‐to‐needle time (DNT) for intravenous thrombolysis in acute ischaemic stroke can lead to improved patient outcomes. Long‐term reports on DNT trends in Australia are lacking in the setting of extension of the thrombolysis time window, addition of mechanical thrombectomy and increasing presentations. Aims: To examine 17‐year trends of DNT and identify factors associated with improved DNT at a high‐volume, metropolitan primary stroke centre. Method: Retrospective study between 2003 and 2019 of all thrombolysis cases using departmental stroke database. Since most strategies were implemented from 2012 onwards, intervention period has been defined as period 2012–2019. Factors associated with DNT reduction were examined by regression modelling. Results: Fifteen strategies were identified including alterations to 'Code Stroke' processes. One thousand, two hundred and fifty patients were thrombolysed, with 737 (58.8%) treated during the intervention period. The proportion of DNT ≤60‐min rose from average of 22.5% during 2003–2012 to 63% during 2015–2018 and 71% in 2019. However, median DNT has only marginally improved from 58 to 51 min between 2015 and 2019. Faster DNT was independently associated with two modifiable workflow factors, 'Direct‐to‐CT' protocol ( P < 0.001) and acute stroke nurse presence ( P < 0.005). Over time, treated patients were older and less independent ( P < 0.001), and the number of annual stroke admissions and 'Code Stroke' activations have risen by fourfold and 10‐fold to 748 and 1298 by 2019 respectively. Conclusions: Targeted quality improvement initiatives are key to reducing thrombolysis treatment delays in the Australian metropolitan setting. Relative stagnation in DNT improvement is concerning and needs further investigation.